Bytey-MV 40.2 Tablet SR
Marketer
Arrient Healthcare Pvt Ltd
Salt Composition
Voglibose (0.2mg) + Metformin (500mg) + Gliclazide (40mg)
Overview Bytey-MV 40.2 Tablet SR
Diabetol-Duo 40.2 Extended-Release Tablets are classified as antidiabetic agents. This combination medication manages type 2 diabetes in adults by regulating blood glucose. Diabetol-Duo 40.2 ER Tablets should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continue this medication as prescribed, even if feeling well or experiencing controlled blood sugar, as discontinuation without medical supervision may elevate blood glucose, increasing the risk of complications such as renal impairment, vision loss, neuropathy, and limb amputation. Remember, this medication is part of a comprehensive diabetes management plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most common adverse effect. Learn to recognize symptoms like sweating, lightheadedness, headache, and trembling, and know how to treat them. Maintain regular mealtimes and carry a readily available fast-acting glucose source, such as sugary snacks or juice. Alcohol consumption should be avoided due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, vomiting, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, and bone fractures. Weight gain may occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before initiating treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Bytey-MV 40.2 Tablet SR
Managing type 2 diabetes
Major Benefits of Bytey-MV 40.2 Tablet SR:
Administer Bytey-MV 40.2 Tablet SR precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Consume with food.
Common Side effects of Bytey-MV 40.2 Tablet SR:
- Nausea
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Constipation
How to use Bytey-MV 40.2 Tablet SR:
Consume Bytey-MV 40.2 Tablet SR precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication should be administered with a meal.
How Bytey-MV 40.2 Tablet SR works:
Extended-release Bytemv 40.2 tablets contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Bytey-MV 40.2 Tablet SR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Bytey-MV 40.2 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingCAUTION
The extended-release Bytey-MV 40.2 Tablet necessitates careful consideration during lactation. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Bytey-MV 40.2 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Bytey-MV 40.2 Tablet SR is contraindicated in those with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Bytey-MV 40.2 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is advised. A low starting dose is typically recommended for those with mild to moderate liver disease; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Bytey-MV 40.2 Tablet SR :
NA
Facts to Know About Bytey-MV 40.2 Tablet SR
| Label | Value |
|---|---|
| Addictive | None. |
| Treatment Category | Medication for diabetes |
3,018 People bought this recently